Enlivex Ltd. (ENLV)

Enlivex Ltd. (ENLV) is a healthcare company (biotechnology) based in Israel. The share price is $1.15, up 2.68% on the day, which values the company at $1.76M. Price as of 17 Nov 2026, 19:09 UTC, from Yahoo Finance.

Key facts

Share price
$1.15+2.68% today
Market value
$1.76M
P/E ratio
0.0×last 12 months
200-week average
$23.1995% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Enlivex Ltd. in more detail

ENLV trades at 0.0× its last twelve months' earnings, -1.5× next year's expected earnings. It sits 95% below its 200-week average of $23.19.

In its favour: More cash than debt. Worth checking: Share count keeps rising; Profit is not turning into cash.

Enlivex Ltd. (ENLV): questions and answers

What is ENLV's P/E ratio?

Enlivex Ltd. trades at 0.0× its last twelve months' earnings and -1.5× next year's expected earnings.

What is Enlivex Ltd.'s market cap?

Enlivex Ltd. is valued at $1.76M at a share price of $1.15.

Is ENLV above its 200-week moving average?

No. ENLV is 95.0% below its 200-week average of $23.19. Long-term investors watch that line because strong companies rarely trade below it for long.

Does ENLV pay a dividend?

Enlivex Ltd. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Enlivex Ltd. (ENLV) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ENLV

Underlying data: Yahoo Finance; company filings with the SEC.